Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A non-encapsulated, well defined pulmonary blastoma, composed of irregular tubular structures. It affects mostly middle-aged adults and it is rare in children. The prognosis is better compared to the biphasic pulmonary blastoma.
Biomarker and diagnostic research for epithelial predominant pulmonary blastoma has been reported in the published literature.
No clinical trials have been registered for epithelial predominant pulmonary blastoma.
4 publications have been identified in PubMed for epithelial predominant pulmonary blastoma. Research spans Case Report / Case Series (75%) and Diagnostic / Biomarker (25%).
Guan J (2025). [PMID: 40848670](https://pubmed.ncbi.nlm.nih.gov/40848670/). *Curr Probl Cancer*. [Case Report / Case Series]
Juarez JE (2025). [PMID: 39980581](https://pubmed.ncbi.nlm.nih.gov/39980581/). *Respirol Case Rep*. [Case Report / Case Series]
Yang L (2025). [PMID: 40594926](https://pubmed.ncbi.nlm.nih.gov/40594926/). *Sci Rep*. [Diagnostic / Biomarker]
Luo S (2025). [PMID: 39807108](https://pubmed.ncbi.nlm.nih.gov/39807108/). *Oncol Lett*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 5:20 PM UTC
AI-curated news mentioning epithelial predominant pulmonary blastoma
Updated Mar 13, 2026
A new study identifies the NFATC2::NUTM2 fusion as a defining feature of a novel primary pulmonary epithelial tumor, highlighting its unique immunophenotype. This discovery could pave the way for targeted therapies and improved diagnostics.